The rise of India's global health diplomacy amid COVID-19 pandemic
- PMID: 38235005
- PMCID: PMC10790121
- DOI: 10.34172/hpp.2023.34
The rise of India's global health diplomacy amid COVID-19 pandemic
Abstract
The COVID-19 pandemic has highlighted the importance of global health diplomacy (GHD), with India emerging as a key player. India's commitment to GHD is demonstrated by its active participation in regional and multilateral projects, pharmaceutical expertise, and large-scale manufacturing capabilities, which include the production and distribution of COVID-19 vaccines and essential medicines. India has supported nations in need through bilateral and multilateral platforms, providing vaccines to countries experiencing shortages and offering technical assistance and capacity-building programs to improve healthcare infrastructure and response capabilities. India's unique approach to GHD, rooted in humanitarian diplomacy, emphasized collaboration and empathy and stressed the well-being of humanity by embracing the philosophy of "Vasudhaiva Kutumbakam," which translates to "the world is one family." Against this background, this paper's main focus is to analyze the rise of India's GHD amidst the COVID-19 pandemic and its leadership in addressing various global challenges. India has demonstrated its commitment to global solidarity by offering medical supplies, equipment, and expertise to more than 100 countries. India's rising global leadership can be attributed to its proactive approach, humanitarian diplomacy, and significant contributions to global health initiatives.
Keywords: COVID-19; Essential medicines; Global health; Health diplomacy; India; Pandemic; Pharmaceuticals; Policy; Vaccines.
© 2023 The Author(s).
Conflict of interest statement
Vijay Kumar Chattu is one of the editorial board members of Health Promotion Perspectives. He is also the Founder and CEO of Global Health Research and Innovations Canada Inc. (GHRIC), Toronto. Other authors declare no competing interests.
Similar articles
-
India's Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective.Cureus. 2024 Oct 5;16(10):e70892. doi: 10.7759/cureus.70892. eCollection 2024 Oct. Cureus. 2024. PMID: 39376975 Free PMC article. Review.
-
COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform.Biomed Res Int. 2021 Aug 26;2021:6658070. doi: 10.1155/2021/6658070. eCollection 2021. Biomed Res Int. 2021. PMID: 34485525 Free PMC article. Review.
-
COVID-19 Vaccine Donations-Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review.Vaccines (Basel). 2021 Sep 15;9(9):1024. doi: 10.3390/vaccines9091024. Vaccines (Basel). 2021. PMID: 34579261 Free PMC article. Review.
-
India's medical devices policy: exploring determinants in business ecosystem for export excellence.J Health Organ Manag. 2025 Mar 10. doi: 10.1108/JHOM-04-2024-0149. Online ahead of print. J Health Organ Manag. 2025. PMID: 40045436
-
Balancing Routine and Pandemic: The Synergy of India's Universal Immunization Program and COVID-19 Vaccination Program.Vaccines (Basel). 2023 Nov 28;11(12):1776. doi: 10.3390/vaccines11121776. Vaccines (Basel). 2023. PMID: 38140180 Free PMC article. Review.
Cited by
-
Nanoparticles of natural product-derived medicines: Beyond the pandemic.Heliyon. 2025 Feb 19;11(4):e42739. doi: 10.1016/j.heliyon.2025.e42739. eCollection 2025 Feb 28. Heliyon. 2025. PMID: 40083991 Free PMC article. Review.
References
-
- Haug S, Roychoudhury S. Civilizational exceptionalism in international affairs: making sense of Indian and Turkish claims. Int Aff. 2023;99(2):531–49. doi: 10.1093/ia/iiac317. - DOI
LinkOut - more resources
Full Text Sources